QMUL aims to create social and economic benefits for society by developing a culture of innovation and enterprise that will facilitate the commercial exploitation of academic research and technology. More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
The CEI is the technology transfer department of the University of Southampton. We are responsible for IP protection, licenses, spinouts and entrepreneurship throughout the University More
Milkhaus Laboratory, Inc. is a clinical stage biopharmaceutical company focused on the treatment of diseases caused by regulatory dysfunction in the immune, endocrine, and nervous systems. More
ReNeuron: developing neural stem cell technology for transplantation & in vitro uses. ReNeuron have licensed, and look to license further, technology which target neurodegenerative diseases More
Displaying 1..10 of 17 -
per page
Next page
Order by